MCON Rasayan India Ltd, a 2016 incorporation, engages in the production, promotion, and retail of contemporary building materials and chemicals. More than 80 products are available from the company, including a variety of building supplies and liquid and powdered construction chemicals.
Ready mix plaster, tile adhesives, block adhesives, wall putty, micro concrete & polymer mortar, engineering non-shrink grouts, and floor hardeners are some of the company’s powder goods. Poly-urethane (PU) based liquid membrane, bonding agents, paints, anti-corrosive coatings, concrete admixtures, and curing agents are examples of items in liquid form. The brand name “MCON” is used to market the goods produced by MCON Rasayan India Ltd.
MCON Rasayan IPO Details
IPO Date
Mar 6, 2023 to Mar 10, 2023
Listing Date
[.]
Face Value
₹10 per share
Price
₹40 per share
Lot Size
3000 Shares
Issue Size
1,710,000 shares of ₹10 (aggregating up to ₹6.84 Cr)
Fresh Issue
1,710,000 shares of ₹10 (aggregating up to ₹6.84 Cr)
De Neers Tools Limited, founded in 1952, is a renowned supplier of industrial tools in India. With a diverse product range including spanners, wrenches, pliers, cutters, allen keys, hammers, socketry, screwdrivers, tool kits, tool cabinets, trolleys, and more, De Neers has established itself as a reliable provider of high-quality tools. The company proudly bears the brand name “De Neers” and has built a strong presence in the market over the years.
With a network of approximately 250 dealers across India, COMPANY has effectively reached customers throughout the country. In addition to general industrial tools, the company specializes in safety tools such as non-sparking tools, insulated steel tools, non-sparking insulated tools, stainless steel and magnetic tools, and titanium tools. This specialization has allowed De Neers to cater to the specific needs of various industries, ensuring the safety and efficiency of their clients’ operations.
IPO opens on Apr 28, 2023, and closes on May 3, 2023.
Event
Tentative Date
Opening Date
Apr 28, 2023
Closing Date
May 3, 2023
Basis of Allotment
May 8, 2023
Initiation of Refunds
May 9, 2023
Credit of Shares to Demat
May 10, 2023
Listing Date
May 11, 2023
UPI Mandate Confirmation Cut-Off Time
5.00 PM on the issue closing day
Industry Overview
The industrial tools industry is driven by the demand for high-quality tools that enhance productivity, efficiency, and safety in industrial operations. Tools provided by companies like De Neers Tools, including spanners, wrenches, pliers, cutters, allen keys, hammers, socketry, screwdrivers, and tool kits, are essential for carrying out a wide range of tasks in different industries.
However, it’s worth noting that the industrial tools sector has historically experienced steady growth, aligning with the expansion of industrial activities worldwide. Factors such as industrial development, infrastructure projects, technological advancements, and increased automation contribute to the growth of the industry.
Company Financials
Period Ended
Total Assets
Total Revenue
Profit After Tax
Net Worth
Reserves and Surplus
Total Borrowing
31-Mar-20
5,570.44
7,349.62
43.94
704.24
712.87
484.58
31-Mar-21
6,111.28
6,211.77
65.77
320.47
317.42
1,147.84
31-Mar-22
9,933.52
8,008.68
504.42
2,382.27
654.27
2,435.85
31-Oct-22
12,558.14
5,602.65
386.98
3,044.13
411.13
2,406.42
Amount in ₹ Lakhs
Objects of the Issue
The proceeds from the issue will be used for the following objects:
1. To meet the working capital requirements of the company. 2. For general corporate purposes and to meet the issue expenses.
Mankind Pharma Limited has emerged as a leading pharmaceutical company focused on developing, manufacturing, and marketing pharmaceutical formulations and consumer healthcare products. With a strong foothold in India, the company operates in diverse therapeutic areas including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. With an extensive portfolio comprising more than 36 well-known brands such as Manforce (Rx), Moxikind-CV, Amlokind-AT, Unwanted-Kit, Candiforce, Gudcef, Glimestar-M, Prega News, Dydroboon, Codistar, Nurokind-Gold, Nurokind Plus-RF, Nurokind-LC, Asthakind-DX, Cefakind, Monticope, Telmikind-H, Telmikind, Gudcef-CV, and Unwanted-72, Mankind Pharma caters to a wide range of healthcare needs.
A key driver behind Mankind Pharma’s success in the Indian pharmaceutical market is its extensive distribution network of medical representatives. This robust presence across the country has fostered trust among healthcare professionals, leading to over 80% of doctors in India prescribing Mankind Pharma’s formulations. This recognition is further reinforced by the company’s remarkable domestic sales performance, securing the fourth position in sales during the Financial Year 2022. Mankind Pharma remains dedicated to fulfilling the healthcare requirements of the Indian population and maintains a steadfast commitment to innovation and growth within the pharmaceutical industry.
Mankind Pharma IPO Details
IPO Date
Apr 25, 2023 to Apr 27, 2023
Listing Date
[.]
Face Value
₹1 per share
Price
₹1026 to ₹1080 per share
Lot Size
13 Shares
Total Issue Size
40,058,844 shares (aggregating up to ₹4,326.36 Cr)
Offer for Sale
40,058,844 shares of ₹1 (aggregating up to ₹4,326.36 Cr)
IPO opens on Apr 25, 2023, and closes on Apr 27, 2023.
Event
Tentative Date
Opening Date
Apr 25, 2023
Closing Date
Apr 27, 2023
Basis of Allotment
May 3, 2023
Initiation of Refunds
May 4, 2023
Credit of Shares to Demat
May 5, 2023
Listing Date
May 8, 2023
UPI Mandate Confirmation Cut-Off Time
5.00 PM on the issue closing day
Company Overview
Mankind Pharma has established itself as a pharmaceutical company with an extensive distribution network of medical representatives, making it one of the largest in the Indian pharmaceutical market. Their reputation is evident as over 80% of doctors in India trust and prescribe their formulations. In terms of domestic sales, the company achieved a notable ranking of fourth during the Financial Year 2022. The company’s achievements have been recognized through various awards and accolades, including the Best of Bharat Awards 2022 by exchange4media and a Silver Medal from the National Awards for Manufacturing Competitiveness Assessment 2021.
With a wide-ranging marketing presence across India, Mankind Pharma employs a dedicated team of 11,691 medical representatives and 3,561 field managers as of December 31, 2022. To support its operations, the company operates 25 manufacturing facilities throughout the country and employs 4,121 manufacturing personnel. Additionally, Mankind Pharma places great emphasis on research and development, boasting a team of over 600 scientists and a dedicated in-house R&D center with four units located in IMT Manesar, Gurugram, Haryana, and Thane, Maharashtra.
Industry Overview
The industry is characterized by rigorous regulatory frameworks, extensive research and development efforts, and a constant drive for innovation. Pharmaceutical companies like Mankind Pharma contribute to the development of new drugs, formulations, and treatment options, addressing a wide range of diseases and medical needs.
In terms of industry growth, the pharmaceutical sector has historically exhibited a positive Compound Annual Growth Rate (CAGR). While specific CAGR figures may vary depending on the timeframe and market conditions, the global pharmaceutical industry has typically shown steady growth due to factors such as an aging population, rising healthcare spending, increasing prevalence of chronic diseases, and advancements in medical technologies.
Company Financials
Period Ended
Total Assets
Total Revenue
Profit After Tax
Net Worth
Reserves and Surplus
Total Borrowing
31-Mar-20
5,073.29
5,975.65
1,056.15
3,485.31
3,436.34
126.92
31-Mar-21
6,372.63
6,385.38
1,293.03
4,722.00
4,674.39
234.53
31-Dec-21
8,043.88
6,218.29
1,260.24
5,965.46
5,916.86
268.70
31-Mar-22
9,147.74
7,977.58
1,452.96
6,155.23
6,106.06
868.03
31-Dec-22
9,273.75
6,777.82
1,015.98
7,145.89
7,094.12
167.93
Amount in ₹ Crore
Key Performance Indicator
KPI
Values
P/E (x)
32.5
Market Cap (₹ Cr.)
43263.6
ROE (%)
27.6
ROCE (%)
26.1
EPS (Rs)
33.2
RoNW (%)
27.7
Objects of the Issue
The company will not receive any proceeds from the offer and all the offer proceeds will be received by the selling shareholders, in proportion to the offered shares sold by the respective selling shareholders as part of the offer.
Piramal Pharma Limited is a leading pharmaceutical company that was incorporated in 2020 as a flagship company of Piramal Group. The company provides pharmaceutical products and services through its domestic and global distribution network. Piramal Pharma has a strong global presence with its 15 manufacturing facilities and a distribution network covering more than 100 countries.
Piramal Pharma includes three major businesses. The first one is Piramal Pharma Solutions (PPS), which is an integrated Contract Development and Manufacturing Organization (CDMO) that offers development and manufacturing solutions to innovators and generic companies across the drug life cycle. The second business is Piramal Critical Care (PCC), which is a Complex Hospital Generics business providing a wide range of products such as inhalation anesthetics, injectable anti-infectives, intrathecal therapies for spasticity and pain management, and other therapies. The third business is the India Consumer Healthcare (ICH) business, which deals with over-the-counter products.
The company intends to utilize the net proceeds from the issue towards the funding of the following objects: 1. Repayment or prepayment, in full or in part, of certain borrowings. 2. General corporate purposes.
PNB Housing Finance Limited is a subsidiary of Punjab National Bank, incorporated in 1988. They provide housing loans to individuals and corporate bodies for various purposes, including construction, purchase, repair, and upgradation of houses, as well as loans for commercial space, purchase of residential plots, loan against properties, and loans for real estate developers. Their target customers include salaried individuals and self-employed customers. The company has a Pan India presence in over 40 locations through a network of 48 branches and 16 hubs. They offer doorstep service for their products through their Direct Sales Team channel, as well as through Direct Marketing Associates and digital media.
The company’s primary focus is to provide housing loans to customers in India, with a particular emphasis on salaried individuals and self-employed customers. They also offer construction finance loans to real estate developers for residential housing. The company has a widespread network of branches and hubs across the country to support its operations. They provide doorstep service to customers through their Direct Sales Team channel, and their products are also sourced through Direct Marketing Associates and digital media.
A G Universal Limited is a company that specializes in supplying industrial MS Tubes, GI Pipes, and Hollow Sections. They offer a broad range of products that includes Stainless Steel Pipes, Mild Steel Pipes, ERW Black Pipes, GI Pipes, Hollow Sections, uPVC Pipes, cPVC Pipes, TMT Bars, Wire Rods, MS Wire, CR Coils, and HR Coils. Their customer base includes prominent companies such as Surya Roshni Limited, Jindal Supreme (India) Private Limited, Swastik Pipe Limited, Ravindra Tubes Private Limited, SKS Ispat & Power Ltd, among others.
Initially established as Akshata Polymers Private Limited, the company started as a petroleum business that dealt with polymers. Over time, they expanded their operations and diversified their product offerings to include industrial tubes and pipes. The company has dealership agreements with many organizations, such as Reliance Industries Ltd., for its petroleum products (polymers/FO/oils) business and imports polymer products from countries such as Korea, China, and Saudi Arabia.
IPO opens on Apr 11, 2023, and closes on Apr 13, 2023.
Event
Tentative Date
Opening Date
Apr 11, 2023
Closing Date
Apr 13, 2023
Basis of Allotment
Apr 19, 2023
Initiation of Refunds
Apr 20, 2023
Credit of Shares to Demat
Apr 21, 2023
Listing Date
Apr 24, 2023
UPI Mandate Confirmation Cut-Off Time
5.00 PM on the issue closing day
Industry Overview
The company operates in the steel and metal industry, specifically in the supply of industrial tubes and pipes. The steel and metal industry is a vital sector that contributes significantly to the global economy, providing raw materials and finished goods to numerous industries. The demand for steel and metal products is high due to their widespread use in construction, infrastructure, transportation, and manufacturing.
The global steel and metal industry has been growing steadily over the years, with a compound annual growth rate (CAGR) of approximately 2.6% from 2016 to 2020. The growth can be attributed to the increasing demand for steel and metal products in emerging economies, as well as the growth of construction and infrastructure projects globally. The industry is expected to continue growing at a CAGR of 3.1% from 2021 to 2026, driven by factors such as increasing urbanization, industrialization, and infrastructure development.
Company Financials
Period Ended
Total Assets
Total Revenue
Profit After Tax
Net Worth
Reserves and Surplus
Total Borrowing
31-Mar-20
1,523.88
2,008.13
4.95
176.04
151.55
784.14
31-Mar-21
1,434.94
3,864.26
14.66
190.71
166.21
944.51
31-Mar-22
1,856.48
7,074.00
70.89
261.60
90.10
942.71
30-Nov-22
2,642.94
3,595.05
114.29
675.88
272.89
950.12
Amount in ₹ Lakhs
Objects of the Issue
The proceeds from the issue will be used for the following objects:
To meet the working capital requirements of the company.
A G Universal Limited F-1, 34/1, Vikas Apartments, East Punjabi Bagh, West Delhi, New Delhi – 110026 Phone: +91 9811100759 Email: info@aguniversal.co.in Website: https://aguniversal.co.in/
Avalon Technologies Limited is an Electronic Manufacturing Services (EMS) company that was founded in 1999. The company has a unique global delivery model that allows them to offer end-to-end capabilities in delivering box-build solutions in India. They are one of the leading companies in the EMS segment in India in terms of revenue in Fiscal 2022.
Avalon Technologies Limited provides a full stack product and solution suite, from PCB design and assembly to the manufacture of complete electronic systems, to global OEMs located in various countries such as China, Netherlands, United States, and Japan. The company’s offerings include PCB design and assembly, cable assembly and wire harnesses, sheet metal fabrication and machining, magnetics, injection molded plastics, and end-to-end box build of electronic systems.
Avalon Technologies IPO Details
IPO Date
Apr 3, 2023 to Apr 6, 2023
Listing Date
Apr 18, 2023
Face Value
₹2 per share
Price
₹415 to ₹436 per share
Lot Size
34 Shares
Total Issue Size
19,839,450 shares (aggregating up to ₹865.00 Cr)
Fresh Issue
7,339,450 shares (aggregating up to ₹320.00 Cr)
Offer for Sale
12,500,000 shares of ₹2 (aggregating up to ₹545.00 Cr)
IPO opens on Apr 3, 2023, and closes on Apr 6, 2023.
Event
Tentative Date
Opening Date
Apr 3, 2023
Closing Date
Apr 6, 2023
Basis of Allotment
Apr 12, 2023
Initiation of Refunds
Apr 13, 2023
Credit of Shares to Demat
Apr 17, 2023
Listing Date
Apr 18, 2023
UPI Mandate Confirmation Cut-Off Time
5.00 PM on the issue closing day
Company Overview
Avalon Technologies Limited is a leading Electronic Manufacturing Services (EMS) company that provides end-to-end capabilities for delivering box-build solutions in India. The company was founded in 1999 and has a unique global delivery model that allows them to offer a full-stack product and solution suite, from printed circuit board (PCB) design and assembly to the manufacture of complete electronic systems (Box Build).
Avalon Technologies Limited has established itself as one of the leaders in the EMS segment in India, with a focus on high-value precision engineered products. The company serves global original equipment manufacturers (OEMs) located in various countries including China, Netherlands, United States, and Japan. Its offerings include PCB design and assembly, cable assembly and wire harnesses, sheet metal fabrication and machining, magnetics, injection molded plastics, and end-to-end box build of electronic systems.
Industry Overview
The electronic manufacturing services (EMS) industry is a fast-growing sector that provides outsourced design, manufacturing, and testing services to various industries such as automotive, aerospace, telecommunications, and consumer electronics. The EMS market is driven by the increasing demand for electronic devices, the need for cost-effective manufacturing solutions, and the growth of the Internet of Things (IoT) and Industry 4.0.
The global EMS market is expected to grow at a compound annual growth rate (CAGR) of around 7% between 2021 and 2026, driven by factors such as the increasing adoption of automation in manufacturing processes, the growth of e-commerce, and the increasing demand for high-quality and reliable electronic products. The EMS market in India is also growing rapidly, driven by factors such as the government’s initiatives to promote electronics manufacturing in the country, the availability of skilled labor at competitive costs, and the increasing demand for electronic products in the domestic market.
Company Financials
Period Ended
Total Assets
Total Revenue
Profit After Tax
Total Borrowing
31-Mar-20
449.65
653.15
12.33
248.48
31-Mar-21
512.48
695.90
23.08
295.33
31-Mar-22
587.96
851.65
68.16
294.05
Amount in ₹ Crore
Objects of the Issue
The Company proposes to utilize the Net Proceeds towards funding the following objects:
Prepayment or repayment of all or a portion of certain outstanding borrowings availed by the Company and one of the Material Subsidiaries, i.e. Avalon Technology and Services Private Limited (ATSPL);
Funding the working capital requirements of the Company;
IRIS Business Services Limited, established in 2000, is a global provider of software products, services, and solutions for compliance, data, and analytics. The company offers a range of innovative products, including IRIS iDEAL, a regulation reporting application designed for banks and financial institutions, IRIS iFILE, an end-to-end data filing platform for regulators, and IRIS CARBON, a cloud-based filing platform that assists companies and mutual funds in meeting their enterprise reporting requirements. They serve enterprises, business registers, central banks, stock exchanges, BFSI organizations, and governments, both domestically and overseas.
In addition to their software products, IRIS Business Services Limited also provides several other solutions, such as the IRIS Data Consumption Platform, which is a structured data repository that enables access to financial and non-financial data of public and private companies. The company’s IRIS FinX is an integrated consolidation application that facilitates end-to-end financial reporting by extracting data from source ERP systems, multiple databases, or spreadsheets. They also offer IRIS GST, an application that assists in filing GST, XBRL conversion, consulting, and training services. IRIS Business Services Limited caters to a wide range of clients, including corporates, banks, mutual funds, and other regulated entities.
The regulatory compliance and reporting industry is a rapidly growing sector, driven by a range of factors such as globalization, increasing regulatory oversight, and technological advancements. The industry is characterized by the need for accurate and timely reporting across various sectors, including banking, finance, healthcare, and others.
The Indian regulatory compliance and reporting industry is expected to grow at a compound annual growth rate (CAGR) of 20% over the next few years, driven by the implementation of new regulations, increasing demand for compliance solutions, and the growing adoption of cloud-based technologies. This growth is expected to be particularly strong in sectors such as banking, financial services, and insurance, where regulatory compliance is a critical aspect of operations.
Company Financials
IRIS Business Services’ financial performance (in INR crore)
FY2013
FY2014
FY2015
FY2016
FY2017
Total revenue
62.9
67.7
55.7
32.8
27.3
Total expenses
50.9
55.7
52.4
40.7
37.5
Profit after tax
7.0
8.0
3.4
6.7
-9.0
Objects of the Issue
The object of the issue are:
1. Repayment of debt 2. Sales & Marketing 3. Expenditure on Product Development 4. General Corporate Purpose
Cholamandalam Investment and Finance Company Limited (Chola), established in 1978, serves as the financial services division of the Murugappa Group. Offering a wide range of financial services including vehicle finance, home loans, home equity loans, SME loans, investment advisory services, and stock broking, Chola has built a strong presence with 1166 branches throughout India. Managing assets worth over INR 1,03,789 Crores and serving more than 21 lakh customers across the country, Chola is a prominent player in the Indian financial services industry.
Cholamandalam Investment NCD April 2023 Detail
Issue Open
Apr 25, 2023 – Apr 27, 2023
Security Name
Cholamandalam Investment and Finance Company Limited
Pattech Fitwell Tube Components Limited was established in 2022, but its journey began a decade ago in 2012. The company specializes in the manufacturing of forging products for the non-automotive sector. Their products include forged flanges, complex and specialized machined components, and welded assemblies in the area of open die forgings.
The company has a total installed capacity of 14104.13 MTPA, which they use to convert semi-finished and raw products into finished products through various value-added processes. These processes include forming, bending, drilling, cutting, inspection, polishing, painting, blasting, welding, punching, marking, testing, and packaging. Company operates in a competitive industry and must continue to produce high-quality products to stay ahead of their competitors.
IPO opens on Apr 5, 2023, and closes on Apr 12, 2023.
Event
Tentative Date
Opening Date
Apr 5, 2023
Closing Date
Apr 12, 2023
Basis of Allotment
Apr 18, 2023
Initiation of Refunds
Apr 19, 2023
Credit of Shares to Demat
Apr 20, 2023
Listing Date
Apr 21, 2023
UPI Mandate Confirmation Cut-Off Time
5.00 PM on the issue closing day
Industry Overview
The company operates in the forging industry, specifically in the manufacturing of forging products for the non-automotive sector. The forging industry plays a critical role in providing raw materials for various industries such as construction, oil and gas, aerospace, and defense. Forged components are preferred over other alternatives due to their superior strength, durability, and resistance to corrosion.
The global forging industry has been growing steadily over the years, with a compound annual growth rate (CAGR) of approximately 5.7% from 2016 to 2020. The growth can be attributed to the increasing demand for forged products in emerging economies, as well as the growth of construction and infrastructure projects globally. The industry is expected to continue growing at a CAGR of 6.2% from 2021 to 2026, driven by factors such as increasing urbanization, industrialization, and infrastructure development.
Company Financials
Period Ended
Total Assets
Total Revenue
Profit After Tax
Net Worth
Reserves and Surplus
Total Borrowing
31-Mar-20
1,155.69
2,038.99
7.74
190.05
0.00
867.72
31-Mar-21
1,386.66
1,844.93
-1.16
321.11
0.00
976.32
31-Mar-22
2,530.38
2,262.87
144.45
563.06
0.00
1,663.56
21-Aug-22
2,572.07
968.72
34.76
569.71
0.00
1,456.31
30-Nov-22
2,661.01
1,137.66
19.69
529.11
19.69
1,745.92
Amount in ₹ Lakhs
Objects of the Issue
The Company proposes to utilize the Net Proceeds from the Issue towards the following objects:
